Endocrinology / diabetes clinical trials recruiting in California

535 recruiting endocrinology / diabetes trials match in California. Showing 20.

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruiting

  Phase 3 · Hoffmann-La Roche · Burbank, California

• Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesRecruiting

  Phase 1 / Phase 2 · University of California, Irvine · Orange, California

• BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)Recruiting

  Phase 1 / Phase 2 · BioInvent International AB · Duarte, California

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Irvine, California

• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruiting

  Phase 2 · Immunovant Sciences GmbH · Huntington Beach, California

• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Recruiting

  Phase 2 · Sparrow Pharmaceuticals · Fountain Valley, California

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · St Leonards

• Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM MetricsRecruiting

  N/A · Milton S. Hershey Medical Center · Los Angeles, California

• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese PatientsRecruiting

  Phase 2 · University of California, San Diego · La Jolla, California

• ExoLuminate Study for Early Detection of Pancreatic CancerRecruiting

  N/A · Biological Dynamics · San Diego, California

• Strategies for Improving Linkage-to-Care After Eye Disease ScreeningRecruiting

  N/A · University of California, San Francisco · San Francisco, California

• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruiting

  N/A · Natera, Inc. · Greenbrae, California

• Study EHR Risk Stratification ToolsRecruiting

  N/A · University of California, Los Angeles · Los Angeles, California

• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Recruiting

  Phase 3 · NRG Oncology · Anaheim, California

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruiting

  Phase 1 · IDEAYA Biosciences · Duarte, California

• DFC 004 Biomarkers for Active Diabetic Foot UlcersRecruiting

  N/A · University of Michigan · San Francisco, California

• A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer SurvivorsRecruiting

  N/A · University of California, Irvine · Irvine, California

• Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaRecruiting

  Phase 3 · SWOG Cancer Research Network · La Jolla, California

• Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemRecruiting

  N/A · Insulet Corporation · Los Angeles, California

• Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian CancerRecruiting

  Phase 1 / Phase 2 · Gilead Sciences · Los Angeles, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.